Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 – final results of the REV1TAL study
Australian Liver Association Clinical Research Network (ALA CRN)
Research output: Contribution to journal › Article › peer-review
12Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 – final results of the REV1TAL study'. Together they form a unique fingerprint.